Vaccines and antibodies in relation to pregnancy and lactation

Hospital Pharmacy

Volumn 34, Issue 8, 1999, Pages 949-960

  Grabenstein, John D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HYPERIMMUNE GLOBULIN; INFLUENZA VACCINE; LYME DISEASE VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RUBELLA VACCINE; TYPHOID VACCINE; VACCINE; YELLOW FEVER VACCINE;

ACTIVE IMMUNIZATION; DRUG RESEARCH; HUMAN; IMMUNOTHERAPY; INFECTION RISK; LACTATION; MEASLES VACCINATION; PASSIVE IMMUNIZATION; PREGNANCY; REVIEW; TETANUS PROPHYLAXIS;

EID: 0033508683     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857879903400809     Document Type: Review

References (47)

1. American College of Obstetricians and Gynecologists. Immunization During Pregnancy (Technical Bulletin No. 160). Washington, DC: ACOG; October 1991.
2. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128-37.
3. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Baltimore, MD: Williams & Wilkins; 1998, 530-5, 1071-90.
4. Trannoy E. Will ethical and liability issues and public acceptance allow maternal immunization? Vaccine. 1998;16:1482-5.
5. Annas GJ, Elias S. Thalidomide and the Titanic: Reconstructing the technology tragedies of the twentieth century. Am J Public Health. 1999;89:98-101.
6. Wilcox A, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-94.
7. Cunningham FG, MacDonald PC, Leveno KJ, et al, ed. Williams Obstetrics. 19th ed. Norwalk, CT: Appleton & Lange; 1993,661-90,919-38.
8. Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR. 1994;43(RR-1):1-38.
9. Linder N, Ohel G. In utero vaccination. Clin Perinatol. 1994;21:663-74.
10. Henderson DA, Moss B. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, ed. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders; 1999,74-97.
11. Halsey NA, Klein D. Maternal immunization. Pediatr Infect Dis J. 1990;9:574-81.
12. Amstey MS. Vaccination in pregnancy. Clin Obstet Gynecol. 1983;10:13-22.
13. Faix RG. Maternal immunization to prevent fetal and neonatal infection. Clin Obstet Gynecol. 1991;34:277-87.
14. Advisory Committee on Immunization Practices. Pneumococcal polysaccharide vaccine. MMWR. 1997;46(RR-8):1-24.
15. Advisory Committee on Immunization Practices. Measles, mumps, and rubella - Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. MMWR. 1998;47(RR-8):1-57.
16. Grabenstein JD. IimnunoFacts: Vaccines and Immunologic Drugs. St Louis, MO: Facts and Comparisons, Inc.; August 1999.
17. Insel RA. Maternal immunization to prevent neonatal infections. N Engl J Med. 1988;319:1219-20.
18. Englund JA, Glezen WP, Thompson C, et al. Haemophilus influenzae type b-specific antibody in infants after maternal immunization. Pediatr Infect Dis J. 1997;16:1122-30.
19. O'Dempsey TJ, McArdle T, Ceesay SJ, et al. Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Childhood. 1996;74:F43-6.
20. Centers for Disease Control and Prevention. Neonatal tetanus - Montana, 1998. MMWR. 1998;47:928-30.
21. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR. 1999;48(RR-4):1-28.
22. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. 1998;16:1456-63.
23. Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997.
24. McCormick JB, Gusmao HH, Nakamura S, et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. J Clin Invest. 1980;65:1141-4.
25. American College of Physicians. Guide for Adult Immunization. 3rd ed. Philadelphia, PA: ACP; 1994.
26. Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome-United States, 1994-1997. MMWR. 1997;46:350-4.
27. Centers for Disease Control. Rubella vaccination during pregnancy-United States, 1971-1988. MMWR. 1989;38:289-93.
28. Jefferson T. Pediatricians alerted to five new vaccines. JAMA. 1999;281:1973-5.
29. Samuel BU, Barry M. The pregnant traveler. Infect Dis Clin N Amer. 1998;12:325-54.
30. Robert E, Vial T, Schaefer C, et al. Exposure to yellow fever vaccine in early pregnancy. Vaccine. 1999;17:283-5.
31. Advisory Committee on Immunization Practices. Prevention of varicella. MMWR. 1996;45(RR-11):1-36.
32. American College of Obstetricians and Gynecologists. Prevention of D Isoimmunization (Technical Bulletin No. 147). Washington, DC: ACOG; October 1990.
33. Chávez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA. 1991;265:3270-4.
34. van Dijk B. Preventing RhD haemolytic disease of the newborn: Give anti-rhesus(D) immunoglobulin to all pregnant women who are Rh negative [editorial]. BMJ. 1997;315:1480-1.
35. Maternal immunization for the prevention of bacterial infection in young infants. Vaccine. 1998;16:1464-7.
36. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease: Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994;16:374-402.
37. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR. 1996;45(RR-7):1-24.
38. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995;96:18-22.
39. Khalak R, Pichichero ME, D'Angio CT. Three-year follow-up of vaccine response in extremely preterm infants. Pediatrics. 1998;101:597-603.
40. Goldman AS. The immune system of human milk: Antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J. 1993;12:664-72.
41. Slade HB, Schwartz SA. Mucosal immunity: The immunology of breast milk. J Allergy Clin Immunol. 1987;80:346-56.
42. Anderson PO. Drug use during breast-feeding. Clin Pharm. 1991;10:59-624.
43. Rennels MB, Wasserman SS, Glass RI, et al. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. Pediatrics. 1995;96:1132-6.
44. Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis. 1996;174(suppl 1):S107-11.
45. Pickering LK, Morrow AL, Herrera I, et al. Effect of maternal rotavirus immunization on milk and serum antibody titers. J Infect Dis. 1995;172:723-8.
46. Insel RA, Amstey M, Pichichero ME. Postimmunization antibody to the Haemophilus influenzae type b capsule in breast milk. J Infect Dis. 1985;152:407-8.
47. Svenerhold AM, Holmgren J, Hanson LA, et al. Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination. Scand J Immunol. 1977;6:1345-9